Your session is about to expire
← Back to Search
Behavioral Intervention for CMV in Pregnancy
Study Summary
This trial will test if a short intervention at a prenatal clinic can help stop CMV infections in pregnant women.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are pregnant and planning to end the pregnancy.You are a mother with a weakened immune system due to HIV or are taking anti-rejection medication after an organ transplant.I plan to give birth outside the University of Alabama at Birmingham hospital.I am scheduled to use immune globulin or antiviral medication.I either do not have CMV antibodies or have a past CMV infection not affecting my current pregnancy.
- Group 1: CMV Risk-Reduction Intervention
- Group 2: Stress Reduction Messaging
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the participant count for this investigation?
"Affirmative, according to the information hosted on clinicaltrials.gov this research study is actively searching for participants. This trial was initially posted on November 1st 2021 and last modified on December 6th 2021; as of now there remains a need for 840 individuals at one medical facility."
Does this experiment include elderly individuals in its participant demographics?
"This trial requires that applicants are between the ages of 14 and 39. There are 26 studies targeting those under the age of majority, while 37 trials cater to individuals over 65 years old."
What is the anticipated outcome of this experiment?
"This clinical trial, monitored from the beginning of enrolment until delivery (32 weeks), is designed to evaluate CMV reinfection rates in non-primary infection women. Its secondary goals are to assess the frequency of CMV shedding through PCR analysis on saliva, urine, and blood specimens; measure any changes in self-reported risk behaviours and protective measures with a questionnaire at 12 week post intervention; as well as determine how often new variants of CMV appear via serological screening assays combined with advanced sequencing methods."
Is this trial of medical treatment still recruiting participants?
"As found on the clinicaltrials.gov website, this medical trial is actively recruiting participants and has been since it was initially published in November 2021; the listing was recently updated in December of that same year."
Is it possible for me to be a participant in this scientific endeavor?
"This research project is seeking 840 individuals aged between 14 and 39 that have contracted cytomegalovirus. To qualify, applicants must be enrolled in prenatal care before the 20th week of gestation and display CMV seronegative status or a pre-existing maternal infection through high IgG avidity index or a positive CMV IgG with negative immunoglobulin M (IgM)."
Share this study with friends
Copy Link
Messenger